Vanda Pharmaceuticals Inc. (VNDA) Social Stream
Vanda Pharmaceuticals Inc (VNDA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VNDA.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued March 27, 2022
The Trend in the Analyst Price Target
Over the past 44 weeks, VNDA's average price target has gone down $11.
VNDA reports an average of 31.34% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VNDA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
VNDA's average broker recommendation rating worsened by 2 over the prior 43 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, Vanda Pharmaceuticals Inc's number of analysts covering the stock is higher than 45.83% of them.
- Vanda Pharmaceuticals Inc's variance in analysts' estimates is lower than -39.65% of Pharmaceutical Products stocks.
- VNDA has a higher upside potential (average analyst target price relative to current price) than 228.85% of Pharmaceutical Products stocks.
- In terms of how Vanda Pharmaceuticals Inc fares relative to Healthcare stocks, note that its average analyst price target is higher than 284.57% of that group.
In the Pharmaceutical Products industry, VKTX, VINC, and VERU are the three stocks most similar to Vanda Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is VNDA a Buy, Hold or Sell? See the POWR Ratings now!